A new vaccine targeting triple-negative breast cancer, the most aggressive form of the disease, has shown encouraging results in early-stage trials. Developed by Anixa Biosciences and the Cleveland Clinic, the vaccine aims to teach the immune system to destroy cancer cells by targeting a specific protein. If approved by the FDA, it could become the first-ever preventative vaccine for breast cancer and revolutionize healthcare.
INDIANAPOLIS — One in eight women will be diagnosed with breast cancer and thousands will die every year, including Hoosiers, according to the American Cancer Society. However, a groundbreaking vaccine under development is making major strides to target the most aggressive form of the disease for the first time.“One day, it might be possible to eliminate breast cancer as a disease,” said Dr. Amit Kumar, the Chairman & CEO of Anixa Biosciences, who helped develop the vaccine.
“To think that you can go get a vaccine that will prevent breast cancer or will prevent a recurrence, that would be huge,”“The only treatment that we have for it is chemotherapy, which has a fair amount of side effects. And we're looking for treatments that are just as effective,” added Dr. Carla Fisher.Fisher is the Division Chief of Breast Surgery at the IU School of Medicine which is also working to develop a vaccine for the disease.
Breast Cancer Vaccine Triple-Negative Breast Cancer Research Healthcare
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Breast, Ovary Removal Can Lengthen Lives of Women With Breast Cancer GenesIt's a decision no woman wants to have to make, but new research shows that young breast cancer patients with high-risk genes may be able to prevent their cancer from returning if they have their breasts or ovaries removed.
Read more »
Alabama Breast Cancer Research Foundation Funds UAB Cancer CenterThe Breast Cancer Research Foundation of Alabama awarded $440,000 to 10 researchers at the UAB’s O’Neal Comprehensive Cancer Center. The funding will support a diverse range of projects focused on understanding the mechanisms of breast cancer, treatment resistance, population health risks, and improving cancer care delivery.
Read more »
Approaches against metastatic breast cancer: mini-tumors from circulating cancer cellsTumor cells circulating in the blood are the 'germ cells' of breast cancer metastases. They are very rare and could not be propagated in the culture dish until now, which made research into therapy resistance difficult.
Read more »
Breast Self-Exams No Longer Recommended, But Breast Awareness Still KeyAlthough formal breast self-exams are no longer recommended by most professional organizations, breast awareness remains important. The article explains the reasoning behind this change, citing studies that found no significant reduction in breast cancer mortality rates among those who performed routine self-exams. However, it emphasizes the continued value of being attuned to changes in breast health and consulting healthcare providers for any concerns.
Read more »
U.S. Surgeon General Warns of Alcohol's Link to CancerThe U.S. Surgeon General, Dr. Vivek Murthy, issued an advisory stating that alcohol consumption is the third leading cause of preventable cancer deaths. He called for clearer labels on alcoholic beverages linking them to cancer risks and urged public health measures to address this issue. Alcohol is linked to an increased risk of seven types of cancer, including breast and colorectal cancer, and is responsible for about 100,000 new cancer cases and 20,000 cancer deaths annually in the U.S.
Read more »
More Women Are Being Diagnosed With Breast Cancer at Later StagesMore breast cancers are being detected later in women, giving the tumors a chance to spread and become life-threatening, a new study finds.
Read more »